The effect of age on race-related breast cancer survival disparities

Annals of Surgical Oncology

Volumn 20, Issue 8, 2013, Pages 2541-2547

  Wray, Curtis J ^a   Phatak, Uma R ^a   Robinson, Emily K ^a   Wiatek, Rebecca L ^a   Rieber, Alyssa G ^b   Gonzalez, Anneliese ^a   Ko, Tien C ^a   Kao, Lillian S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HAZARD RATIO; HEALTH CARE DISPARITY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MULTICENTER STUDY; OVERALL SURVIVAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK FACTOR; TRIPLE NEGATIVE BREAST CANCER;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CONFIDENCE INTERVALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84880265236     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-2913-x     Document Type: Article

References (33)

1. American Cancer Society. Breast cancer facts and figures, 2011-2012. Atlanta: American Cancer Society, 2012.
2. Freedman RA, Virgo KS, He Y, et al. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer. 2011;117:180-9.
3. Adams, SA, WM Butler, J. Fulton, et al. Racial disparities in breast cancer mortality in a multiethnic cohort in the Southeast. Cancer. 2012;118:2693-9.
4. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94:490-6.
5. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409-18.
6. Lipscomb J, Gillespie TW, Goodman M, et al. Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US. Breast Cancer Res Treat. 2012;133:285-96.
7. Edge SB, American Joint Committee on Cancer; and American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed. New York: Springer, 2010.
8. Miranda PY, Tarraf W, Gonzalez HM. Breast cancer screening and ethnicity in the United States: implications for health disparities research. Breast Cancer Res Treat. 2011;128:535-42.
9. Fedewa SA, Edge SB, Stewart AK, Halpern MT, Marlow NM, Ward EM. Race and ethnicity are associated with delays in breast cancer treatment (2003-2006). J Health Care Poor Underserved. 2011;22:128-41.
10. Castro-Echeverry E, Kao LS, Robinson EK, Silberfein EJ, Ko TC, Wray CJ. Relationship between documentation status and survival for medically underserved Hispanic breast cancer patients. J Surg Res. 2012 [Epub ahead of print].
11. Vona-Davis L, Rose DP. The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health. 2009;18:883-93.
12. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-87.
13. Castro-Echevarry E, Kao LS, Wray CJ. Undocumented status does not decrease survival in medically-underserved breast cancer patients. J Surg Res. 2011;165:178.
14. Harrell WA, Spaulding LM. Social psychological models of choice behavior and drivers' left turns. J Soc Psychol. 2001;141:714-22.
15. Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338:b604.
16. Hosmer DW Lemeshow S, May S. Applied survival analysis: regression modeling of time-to-event data. 2nd ed. Hoboken: Wiley-Interscience, 2008.
17. Cleves MA. An introduction to survival analysis using Stata. 3rd ed. College Station: Stata Press, 2010.
18. Royston P. Flexible parametric alternatives to the Cox model, and more. Stata J. 2001;1:1-28.
19. Cummings P. Estimating adjusted risk ratios for matched and unmatched data: an update. Stata J. 2011;11:290-8.
20. Ooi SL, Martinez ME, Li CI. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat. 2011;127:729-38.
21. Reeder-Hayes KE, Bainbridge J, Meyer AM, et al. Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat. 2011;128:863-71.
22. Sail K, Franzini L, Lairson D, Du X. Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer. Ethn Health. 2012;17:309-23.
23. Whitman S, Ansell D, Orsi J, Francois T. The racial disparity in breast cancer mortality. J Community Health. 2011;36:588-96.
24. van de Water W, Markopoulos C, van de Velde CJ, et al. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptorpositive breast cancer. JAMA. 2012;307:590-7.
25. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007;109:1721-8.
26. Stead LA, Lash TL, Sobieraj JE, et al. Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res. 2009;11:R18.
27. Wheeler SB, Carpenter WR, Peppercorn J, Schenck AP, Weinberger M, Biddle AK. Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer. Breast Cancer Res Treat. 2012;131:207-16.
28. National Cancer Institute, Surveillance Epidemiology and End Results (SEER). Cancer statistics. http://seer.cancer.gov/statistics/. Accessed 20 Dec 2012.
29. Swede H, Gregorio DI, Tannenbaum SH, et al. Prevalence and prognostic role of triple-negative breast cancer by race: a surveillance study. Clin Breast Cancer. 2011;11:332-41.
30. Sparano JA, Wang M, Zhao F, et al. Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst. 2012;104:406-14.
31. Fedewa SA, Ward EM, Stewart AK, Edge SB. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. J Clin Oncol. 2010;28:4135-41.
32. Wu XC, Lund MJ, Kimmick GG, et al. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol. 2012;30:142-50.
33. Cox DR. Regression models and life tables. R Stat Soc B. 1972;34:187-220.